Laxeerdrank

Lactulose, the active ingredient in Laxeerdrank, is an osmotic laxative presented as an oral solution for oral use. It softens stool and reduces ammonia absorption, making it useful for treating constipation and hepatic encephalopathy in adults. GNH USA supplies Laxeerdrank as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lactulose acts as an osmotic laxative and ammonia‑lowering agent, addressing conditions related to bowel motility and liver‑derived neurotoxicity. - Constipation: softens stool and promotes regular bowel movements. - Hepatic encephalopathy: lowers blood ammonia levels to improve neurological symptoms. - Hyperammonemia: reduces systemic ammonia concentrations in patients with liver disease.

Lactulose is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Flatulence: increased intestinal gas production. - Abdominal cramps: intermittent stomach discomfort. - Diarrhea: loose stools, especially at higher doses. - Nausea: mild queasiness after ingestion. - Bloating: sensation of abdominal fullness.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss from prolonged diarrhea. - Electrolyte imbalance: disturbances in sodium, potassium, or calcium levels. - Allergic reaction: rash, itching, or swelling of the face and throat.

Lactulose should be used with attention to patient‑specific factors and proper storage. - Renal function assessment: evaluate kidney status before initiating therapy. - Electrolyte monitoring: check serum electrolytes during prolonged use. - Diabetes caution: monitor blood glucose as lactulose may affect sugar levels. - Galactosemia avoidance: contraindicated in patients with this metabolic disorder. - Hepatic impairment adjustment: consider dose modification in severe liver disease. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lactulose may interact with other medicines, requiring vigilance.

Major Interactions (Avoid): - Antacids containing magnesium: can reduce lactulose efficacy. - Oral antibiotics: may alter colonic flora and diminish lactulose activity. - Diuretics: increase risk of electrolyte disturbances when combined with lactulose‑induced diarrhea.

Moderate Interactions (Monitor Closely): - Metformin: may exacerbate gastrointestinal side effects. - Levothyroxine: absorption may be impaired; monitor thyroid function. - Warfarin: potential alteration of INR; regular coagulation monitoring advised.